Table 3.
Epigenomic Aberrations and Their Target Genes in ESCC
| Epigenomic regulation | Coding or noncoding genes | Cancer-associated alterations | |
|---|---|---|---|
| DNA methylation | Coding genes: TFF148, Bin1119, NID2120, PTPN22121, PRSS8122, KLF4123, HIC1124, RASSF245, RASSF1A125, RASSF5A126, PAR4127, FBXO32128, IGFBP7129, SPINT2130, ADAMTS8131, DIRAS1132, Rab25133, PTK6134, CDH1135, UPK1A136, HIN-1137, DCC138, PLCD1139, CRABP1140, LRP1B26, RARβ141, TSLC1142,143, CDKN2A/B42,43, DLC145, FHIT144 | Promoter hypermethylation with decreased transcription | |
| Non-coding RNAs: miR-21833, miR-12634, nc88635, miR-34a36 miR-37537 | Promoter hypermethylation with decreased transcription | ||
| NGALR145, LINE-153–56 | Hypomethylation | ||
| Chromatin modification | Histone writers | EP300, CREBBP, MLL, MLL2, MLL3, NSD1, SETD2, JARID2 | Somatic mutations |
| EZH261, G9a62 | Increased transcription | ||
| Histone erasers | KDM6A, TET2, NCOR2 | Somatic mutations | |
| HDAC4146 | Increased transcription | ||
| Chromatin remodelers | ARID1A, ARID2, SMARCC2 | Somatic mutations | |
| RNA editing | ADAR171 | Gene amplification with increased transcription | |
| ADAR272 | Decreased transcription | ||